09:53 AM EST - Angiotech Pharmaceuticals Inc. : reported a fourth-quarter net loss of $77.0 million U.S. or $0.90 U.S. per share, compared to a loss of $27.9 million U.S. or $0.29 U.S. per share in the same quarter last year. On an adjusted basis, net loss was $2.6 million U.S. or $0.03 U.S. per share, compared to a loss of $17.0 million U.S. or $0.20 U.S. per share in the year ago quarter. On average, two analysts polled by Thomson Reuters expected the company to report a loss of $0.01 U.S. per share for the quarter. Analysts' estimates typically exclude special items. Revenue for the quarter decreased to $62.1 million U.S. from $71.4 million U.S. in the comparable quarter last year. Angiotech Pharmaceuticals Inc.
shares T.ANP are trading down $0.02 at $0.43.
